Promega Corporation

TGFß1 Emax® ImmunoAssay System Technical Bulletin

Literature # TB196

The TGFβ1 Emax® ImmunoAssay System allows sensitive and specific detection of biologically active TGFβ1 in an antibody sandwich format. In this format, flat-bottom 96-well plates are coated with TGFβ Coat mAb, which binds soluble TGFβ1. The captured TGFβ1 is bound by a second specific polyclonal antibody (pAb). After washing, the amount of specifically bound pAb is detected using a species-specific antibody conjugated to horseradish peroxidase (TGFβ HRP Conjugate) as a tertiary reactant. The unbound conjugate is removed by washing and, following an incubation with a chromogenic substrate, the color change is measured. The amount of TGFβ1 in the test solutions is proportional to the color generated in the oxidation-reduction reaction. Using this system, biologically active TGFβ1 in tissue culture supernatants, plasma, serum or urine can be quantitated in the range of 32–1,000pg/ml.

The TGFβ1 Emax® ImmunoAssay System offers several benefits:


  • Specificity: Specific detection of TGFβ1; typically less than or equal to 3% cross-reactivity with TGFβ2 and TGFβ3 at 10ng/ml.

  • Sensitivity: Detects a minimum of 32pg/ml of TGFβ1.

  • Flexibility: ELISA plates can be set up in any desired configuration.

  • High Value: Optimized reagents and protocol.


Printed in USA. Revised 7/11.

PDF Icon Complete Protocol PDF (679kb)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »